全球药物发现资讯学市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

全球药物发现资讯学市场规模预计将从 2024 年的 36.4743 亿美元增长到 2033 年的 79.8427 亿美元，在 2026 年至 2033 年的预测期内呈现 9.1% 的强劲年复合成长率(CAGR)。

药物研发资讯学市场正在经历显着的成长，这得益于药物开发过程日益复杂以及对高效资料管理解决方案的需求。药物发现资讯学涵盖一系列工具和技术，有助于在整个药物开发生命週期中分析、视觉化和管理生物和化学资料。随着製药公司寻求加快其研发力度，对增强协作和资料整合的资讯解决方案的需求预计将上升，从而使该市场实现强劲扩张。

此外，资讯科技的进步正在推动药物发现资讯学市场的创新。人工智慧 (AI)、机器学习 (ML) 和巨量资料分析的融合正在改变研究人员分析大量资料集的方式，从而能够更有效地识别潜在的候选药物。这些技术促进了预测模型、虚拟筛选和资料探勘，大大减少了与药物发现相关的时间和成本。随着研究不断探索药物发现资讯学的新方法和新应用，在药物开发效率提高和创新的推动下，市场可能会进一步扩大。

此外，研究机构和製药公司之间越来越重视合作和资料共享，这正在塑造药物发现资讯学格局。随着利害关係人认识到协作研究努力的价值，对支援跨平台资料整合和共享的资讯解决方案的需求可能会增加。这一趋势在开放科学倡议的背景下尤其重要，因为资料的透明度和可近性对于推进药物研发工作至关重要。随着药物发现资讯学市场不断发展，技术进步、协作研究模式和对数据驱动决策的关注将在塑造其未来发展方面发挥关键作用。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：药物发现资讯学产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 市场吸引力分析：按应用
  • 按功能分析市场吸引力
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球药物发现资讯学市场分析：按应用

• 概述：按应用
• 历史和预测数据分析：按应用
• 药物研发
• 药物开发

第 6 章：全球药物发现资讯学市场分析：按功能

• 功能概览
• 按功能进行历史和预测资料分析
• 定序和目标资料分析
• 文库和资料库准备
• 对接、分子建模
• 其他的

第 7 章：全球药物发现资讯学市场分析：按最终用户

• 最终用户概览
• 最终用户的历史和预测数据分析
• 生技公司
• 製药公司
• 合约研究组织
• 其他的

第 8 章：全球药物发现资讯学市场分析：按地理区域划分

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测数据销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 9 章：药物发现资讯学公司的竞争格局

• 药物发现资讯学市场竞争
• 伙伴关係/合作/协议
• 合併与收购
• 新产品发布
• 其他进展

第十章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Certara
• 公司概况
• 公司收入
• 产品
• 最新动态
• Boehringer Ingelheim International GmbH
• 公司概况
• 公司收入
• 产品
• 最新动态
• Infosys Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Charles River Laboratories
• 公司概况
• 公司收入
• 产品
• 最新动态
• Collaborative Drug Discovery Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Eurofins DiscoverX Products
• 公司概况
• 公司收入
• 产品
• 最新动态
• Jubliant Biosys
• 公司概况
• 公司收入
• 产品
• 最新动态
• Selvita
• 公司概况
• 公司收入
• 产品
• 最新动态
• Novo Informatics Pvt. Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• ChemAxon Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Albany Molecular Research Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Oracle
• 公司概况
• 公司收入
• 产品
• 最新动态
• Accenture
• 公司概况
• 公司收入
• 产品
• 最新动态
• Agilent Technologies Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Illumina Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Global Drug Discovery Informatics Market size is anticipated to grow from USD 3647.43 Million in 2024 to USD 7984.27 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period of 2026 to 2033.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

• Drug Discovery
• Drug Development

By Function

• Sequencing and Target Data Analysis
• Library and Database Preparation
• Docking
• Molecular Modelling
• Others

By End User

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Other End Users
• COMPANIES PROFILED
• Certara Inc.
• Accenture
• Thermo Fisher Scientific Inc.
• Jubilant Pharmova
• Oracle Corporation
• Albany Molecular Research Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. DRUG DISCOVERY INFORMATICS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Application
  • 3.7.2 Market Attractiveness Analysis By Function
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY APPLICATION

• 5.1. Overview By Application
• 5.2. Historical and Forecast Data Analysis By Application
• 5.3. Drug Discovery Historic and Forecast Sales By Regions
• 5.4. Drug Development Historic and Forecast Sales By Regions

6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY FUNCTION

• 6.1. Overview By Function
• 6.2. Historical and Forecast Data Analysis By Function
• 6.3. Sequencing and Target Data Analysis Historic and Forecast Sales By Regions
• 6.4. Library and Database Preparation Historic and Forecast Sales By Regions
• 6.5. Docking, Molecular Modelling Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY END USER

• 7.1. Overview By End User
• 7.2. Historical and Forecast Data Analysis By End User
• 7.3. Biotechnology Companies Historic and Forecast Sales By Regions
• 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 7.5. Contract Research Organizations Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DISCOVERY INFORMATICS COMPANIES

• 9.1. Drug Discovery Informatics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF DRUG DISCOVERY INFORMATICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Certara
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Boehringer Ingelheim International GmbH
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Infosys Ltd.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Charles River Laboratories
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Collaborative Drug Discovery Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Eurofins DiscoverX Products
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Jubliant Biosys
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Selvita
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Novo Informatics Pvt. Ltd.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. ChemAxon Ltd.
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Albany Molecular Research Inc.
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Oracle
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Accenture
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments
• 10.16. Agilent Technologies Inc.
  • 10.16.1 Company Overview
  • 10.16.2 Company Revenue
  • 10.16.3 Products
  • 10.16.4 Recent Developments
• 10.17. Illumina Inc
  • 10.17.1 Company Overview
  • 10.17.2 Company Revenue
  • 10.17.3 Products
  • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Application (USD MN)
• Drug Discovery Market Sales By Geography (USD MN)
• Drug Development Market Sales By Geography (USD MN)
• Analysis By Function (USD MN)
• Sequencing and Target Data Analysis Market Sales By Geography (USD MN)
• Library and Database Preparation Market Sales By Geography (USD MN)
• Docking, Molecular Modelling Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Drug Discovery Informatics Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Discovery Informatics Report
• Market Research Process
• Market Research Methodology
• Global Drug Discovery Informatics Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By Function
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Application (USD MN)
• Drug Discovery Market Sales By Geography (USD MN)
• Drug Development Market Sales By Geography (USD MN)
• Global Market Analysis By Function (USD MN)
• Sequencing and Target Data Analysis Market Sales By Geography (USD MN)
• Library and Database Preparation Market Sales By Geography (USD MN)
• Docking, Molecular Modelling Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Biotechnology Companies Market Sales By Geography (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.